Addex Therapeutics is pioneering discovery and development of an emerging class of oral small molecule drugs, called allosteric modulators, which can be selective for their intended target and confer significant therapeutic advantages over conventional orthosteric small molecule or biological drugs.

Location

Chemin des Mines 9, 1202 Geneva, Switzerland

Facts & figures
  • Type of organization

    Public company

  • Year of foundation

    2002

  • Number of employees in Switzerland

    20-49

Key business